サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1473843

B型肝炎ワクチンの世界市場（2024年）

Global Hepatitis B Vaccines Market Research Report 2024
出版日: | 発行: QYResearch | ページ情報: 英文 122 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.91円
B型肝炎ワクチンの世界市場（2024年）
出版日: 2024年05月07日
発行: QYResearch
ページ情報: 英文 122 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のB型肝炎ワクチンの市場規模は、2023年に12億6,900万米ドルであり、2030年までに19億8,500万米ドルに達すると予測され、2024年～2030年の予測期間にCAGRで6.45％の成長が見込まれます。

北米の市場規模は、2023年の5億6,800万米ドルから2030年までに9億6,400万米ドルに達すると推定され、予測期間のCAGRは7.48%です。

アジア太平洋の市場規模は、2023年の3億9,750万米ドルから2030年までに5億5,468万米ドルに達すると推定され、予測期間のCAGRは4.92％です。

世界のB型肝炎ワクチンの主要メーカーは、GSK、NCPC、Merck、Bio Kangtai、Dynavax、AIM Vaccine、KM Biologics、LG Life Sciences、Serum Instituteなどです。2023年、世界の上位5ベンダーが収益の約79.66%を占めました。

当レポートでは、世界のB型肝炎ワクチン市場について調査分析し、各地域の市場規模と予測、企業プロファイル、技術動向、新製品開発などの情報を提供しています。

目次

第1章 B型肝炎ワクチン市場の概要

  • 製品定義
  • B型肝炎ワクチン：タイプ別
    • 世界のB型肝炎ワクチンの市場金額の比較：タイプ別（2024年～2030年）
    • 酵母由来
    • CHO由来
  • B型肝炎ワクチン：用途別
    • 世界のB型肝炎ワクチンの市場金額：用途別（2024年～2030年）
    • 小児
    • 成人
  • 世界のB型肝炎ワクチンの市場規模の推計と予測
    • 世界のB型肝炎ワクチンの収益（2019年～2030年）
    • 世界のB型肝炎ワクチンの売上（2019年～2030年）
    • 世界のB型肝炎ワクチン市場の平均価格（2019年～2030年）
  • 前提条件と制限

第2章 B型肝炎ワクチン市場競合

  • 世界のB型肝炎ワクチンの売上の市場シェア：メーカー別（2019年～2024年）
  • 世界のB型肝炎ワクチンの収益の市場シェア：メーカー別（2019年～2024年）
  • 世界のB型肝炎ワクチンの平均価格：メーカー別（2019年～2024年）
  • 世界のB型肝炎ワクチンの主要企業、産業ランキング（2022年・2023年・2024年）
  • 世界のB型肝炎ワクチンの主要メーカー、製造拠点、本社
  • 世界のB型肝炎ワクチンの主要メーカー、製品タイプ、用途
  • 世界のB型肝炎ワクチンの主要メーカー、業界参入日
  • 世界のB型肝炎ワクチン市場の競合情勢と動向
    • 世界のB型肝炎ワクチンの市場集中度
    • 世界の5大・9大B型肝炎ワクチンメーカーの収益の市場シェア
    • 世界のB型肝炎ワクチン市場：企業タイプ別（Tier 1・Tier 2・Tier 3）
  • メーカーの合併と買収、拡張計画

第3章 世界のB型肝炎ワクチン市場情勢：地域別

  • 世界のB型肝炎ワクチンの市場規模：地域別（2019年・2023年・2030年）
  • 世界のB型肝炎ワクチンの売上：地域別（2019年～2030年）
    • 世界のB型肝炎ワクチンの売上：地域別（2019年～2024年）
    • 世界のB型肝炎ワクチンの売上：地域別（2025年～2030年）
  • 世界のB型肝炎ワクチンの収益：地域別（2019年～2030年）
    • 世界のB型肝炎ワクチンの収益：地域別（2019年～2024年）
    • 世界のB型肝炎ワクチンの収益：地域別（2025年～2030年）
  • 北米のB型肝炎ワクチン市場の事実と数置：国別
    • 北米のB型肝炎ワクチンの市場規模：国別（2019年・2023年・2030年）
    • 北米のB型肝炎ワクチンの売上：国別（2019年～2030年）
    • 北米のB型肝炎ワクチンの収益：国別（2019年～2030年）
    • 米国
    • カナダ
    • メキシコ
  • 欧州のB型肝炎ワクチン市場の事実と数置：国別
    • 欧州のB型肝炎ワクチンの市場規模：国別（2019年・2023年・2030年）
    • 欧州のB型肝炎ワクチンの売上：国別（2019年～2030年）
    • 欧州のB型肝炎ワクチンの収益：国別（2019年～2030年）
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ベネルクス
  • アジア太平洋のB型肝炎ワクチン市場の事実と数置：地域別
    • アジア太平洋のB型肝炎ワクチンの市場規模：地域別（2019年・2023年・2030年）
    • アジア太平洋のB型肝炎ワクチンの売上：地域別（2019年～2030年）
    • アジア太平洋のB型肝炎ワクチンの収益：地域別（2019年～2030年）
    • 中国
    • 日本
    • 韓国
    • インド
    • 東南アジア
  • 南米のB型肝炎ワクチン市場の事実と数置：国別
    • 南米のB型肝炎ワクチンの市場規模：国別（2019年・2023年・2030年）
    • 南米のB型肝炎ワクチンの売上：国別（2019年～2030年）
    • 南米のB型肝炎ワクチンの収益：国別
    • ブラジル
  • 中東・アフリカのB型肝炎ワクチン市場の事実と数置：国別
    • 中東・アフリカのB型肝炎ワクチンの市場規模：国別（2019年・2023年・2030年）
    • 中東・アフリカのB型肝炎ワクチンの売上：国別（2019年～2030年）
    • 中東・アフリカのB型肝炎ワクチンの収益：国別
    • 中東
    • アフリカ

第4章 セグメント：タイプ別

  • 世界のB型肝炎ワクチンの売上：タイプ別（2019年～2030年）
    • 世界のB型肝炎ワクチンの売上の内訳：タイプ別（2019年～2024年）
    • 世界のB型肝炎ワクチンの売上：タイプ別（2025年～2030年）
    • 世界のB型肝炎ワクチンの売上の市場シェア：タイプ別（2019年～2030年）
  • 世界のB型肝炎ワクチンの収益：タイプ別（2019年～2030年）
    • 世界のB型肝炎ワクチンの収益：タイプ別（2019年～2024年）
    • 世界のB型肝炎ワクチンの収益：タイプ別（2025年～2030年）
    • 世界のB型肝炎ワクチンの収益の市場シェア：タイプ別（2019年～2030年）
  • 世界のB型肝炎ワクチンの価格：タイプ別（2019年～2030年）

第5章 セグメント：用途別

  • 世界のB型肝炎ワクチンの売上：用途別（2019年～2030年）
    • 世界のB型肝炎ワクチンの売上：用途別（2019年～2024年）
    • 世界のB型肝炎ワクチンの売上：用途別（2025年～2030年）
    • 世界のB型肝炎ワクチンの売上の市場シェア：用途別（2019年～2030年）
  • 世界のB型肝炎ワクチンの収益：用途別（2019年～2030年）
    • 世界のB型肝炎ワクチンの収益：用途別（2019年～2024年）
    • 世界のB型肝炎ワクチンの収益：用途別（2025年～2030年）
    • 世界のB型肝炎ワクチンの収益の市場シェア：用途別（2019年～2030年）
  • 世界のB型肝炎ワクチンの価格：用途別（2019年～2030年）

第6章 主要企業のプロファイル

  • GSK
  • NCPC
  • Merck
  • Bio Kangtai
  • Dynavax
  • AIM Vaccine
  • KM Biologics
  • LG Life Sciences
  • Serum Institute

第7章 産業チェーンと販売チャネルの分析

  • B型肝炎ワクチンの産業チェーン分析
  • B型肝炎ワクチンの主な原材料
    • 主な原材料
    • 原材料の主要サプライヤー
  • B型肝炎ワクチンの生産方式とプロセス
  • B型肝炎ワクチンの販売とマーケティング
    • B型肝炎ワクチンの販売チャネル
    • B型肝炎ワクチンの販売業者
  • B型肝炎ワクチンの顧客

第8章 B型肝炎ワクチンの市場力学

  • B型肝炎ワクチン産業の動向
  • B型肝炎ワクチン市場の促進要因
  • B型肝炎ワクチン市場の課題
  • B型肝炎ワクチン市場の抑制要因

第9章 調査結果と結論

第10章 調査手法とデータソース

図表

List of Tables

  • Table 1. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
  • Table 2. Major Manufacturers of Yeast Derived
  • Table 3. Major Manufacturers of CHO Derived
  • Table 4. Global Hepatitis B Vaccines Market Value by Application (2024-2030) & (US$ Million)
  • Table 5. Global Hepatitis B Vaccines Market Competitive Situation by Manufacturers in 2023
  • Table 6. Global Hepatitis B Vaccines Sales (M Doses) of Key Manufacturers (2019-2024)
  • Table 7. Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
  • Table 8. Global Hepatitis B Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
  • Table 9. Global Hepatitis B Vaccines Revenue Share by Manufacturers (2019-2024)
  • Table 10. Global Market Hepatitis B Vaccines Average Price (USD/Doses) of Key Manufacturers (2019-2024)
  • Table 11. Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
  • Table 12. Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
  • Table 13. Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
  • Table 14. Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
  • Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 16. Global Hepatitis B Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatitis B Vaccines as of 2023)
  • Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans
  • Table 18. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
  • Table 19. Global Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
  • Table 20. Global Hepatitis B Vaccines Sales Market Share by Region (2019-2024)
  • Table 21. Global Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
  • Table 22. Global Hepatitis B Vaccines Sales Market Share by Region (2025-2030)
  • Table 23. Global Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
  • Table 24. Global Hepatitis B Vaccines Revenue Market Share by Region (2019-2024)
  • Table 25. Global Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
  • Table 26. Global Hepatitis B Vaccines Revenue Market Share by Region (2025-2030)
  • Table 27. North America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 28. North America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
  • Table 29. North America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
  • Table 30. North America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
  • Table 31. North America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
  • Table 32. Europe Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 33. Europe Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
  • Table 34. Europe Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
  • Table 35. Europe Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
  • Table 36. Europe Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
  • Table 37. Asia Pacific Hepatitis B Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 38. Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2024) & (M Doses)
  • Table 39. Asia Pacific Hepatitis B Vaccines Sales by Region (2025-2030) & (M Doses)
  • Table 40. Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2024) & (US$ Million)
  • Table 41. Asia Pacific Hepatitis B Vaccines Revenue by Region (2025-2030) & (US$ Million)
  • Table 42. South America Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 43. South America Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
  • Table 44. South America Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
  • Table 45. South America Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
  • Table 46. South America Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
  • Table 47. Middle East and Africa Hepatitis B Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
  • Table 48. Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2024) & (M Doses)
  • Table 49. Middle East and Africa Hepatitis B Vaccines Sales by Country (2025-2030) & (M Doses)
  • Table 50. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2019-2024) & (US$ Million)
  • Table 51. Middle East and Africa Hepatitis B Vaccines Revenue by Country (2025-2030) & (US$ Million)
  • Table 52. Global Hepatitis B Vaccines Sales (M Doses) by Type (2019-2024)
  • Table 53. Global Hepatitis B Vaccines Sales (M Doses) by Type (2025-2030)
  • Table 54. Global Hepatitis B Vaccines Sales Market Share by Type (2019-2024)
  • Table 55. Global Hepatitis B Vaccines Sales Market Share by Type (2025-2030)
  • Table 56. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2019-2024)
  • Table 57. Global Hepatitis B Vaccines Revenue (US$ Million) by Type (2025-2030)
  • Table 58. Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2024)
  • Table 59. Global Hepatitis B Vaccines Revenue Market Share by Type (2025-2030)
  • Table 60. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2024)
  • Table 61. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2025-2030)
  • Table 62. Global Hepatitis B Vaccines Sales (M Doses) by Application (2019-2024)
  • Table 63. Global Hepatitis B Vaccines Sales (M Doses) by Application (2025-2030)
  • Table 64. Global Hepatitis B Vaccines Sales Market Share by Application (2019-2024)
  • Table 65. Global Hepatitis B Vaccines Sales Market Share by Application (2025-2030)
  • Table 66. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2019-2024)
  • Table 67. Global Hepatitis B Vaccines Revenue (US$ Million) by Application (2025-2030)
  • Table 68. Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2024)
  • Table 69. Global Hepatitis B Vaccines Revenue Market Share by Application (2025-2030)
  • Table 70. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2024)
  • Table 71. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2025-2030)
  • Table 72. GSK Company Information
  • Table 73. GSK Description and Business Overview
  • Table 74. GSK Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 75. GSK Hepatitis B Vaccines Product
  • Table 76. NCPC Company Information
  • Table 77. NCPC Description and Business Overview
  • Table 78. NCPC Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 79. NCPC Hepatitis B Vaccines Product
  • Table 80. Merck Company Information
  • Table 81. Merck Description and Business Overview
  • Table 82. Merck Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 83. Merck Hepatitis B Vaccines Product
  • Table 84. Bio Kangtai Company Information
  • Table 85. Bio Kangtai Description and Business Overview
  • Table 86. Bio Kangtai Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 87. Bio Kangtai Hepatitis B Vaccines Product
  • Table 88. Dynavax Company Information
  • Table 89. Dynavax Description and Business Overview
  • Table 90. Dynavax Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 91. Dynavax Hepatitis B Vaccines Product
  • Table 92. Dynavax Recent Developments/Updates
  • Table 93. AIM Vaccine Company Information
  • Table 94. AIM Vaccine Description and Business Overview
  • Table 95. AIM Vaccine Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 96. AIM Vaccine Hepatitis B Vaccines Product
  • Table 97. KM Biologics Company Information
  • Table 98. KM Biologics Description and Business Overview
  • Table 99. KM Biologics Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 100. KM Biologics Hepatitis B Vaccines Product
  • Table 101. LG Life Sciences Company Information
  • Table 102. LG Life Sciences Description and Business Overview
  • Table 103. LG Life Sciences Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 104. LG Life Sciences Hepatitis B Vaccines Product
  • Table 105. LG Life Sciences Recent Developments/Updates
  • Table 106. Serum Institute Company Information
  • Table 107. Serum Institute Description and Business Overview
  • Table 108. Serum Institute Hepatitis B Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Doses) and Gross Margin (2019-2024)
  • Table 109. Serum Institute Hepatitis B Vaccines Product
  • Table 110. Key Raw Materials Lists
  • Table 111. Raw Materials Key Suppliers Lists
  • Table 112. Hepatitis B Vaccines Distributors List
  • Table 113. Hepatitis B Vaccines Customers List
  • Table 114. Hepatitis B Vaccines Market Trends
  • Table 115. Hepatitis B Vaccines Market Drivers
  • Table 116. Hepatitis B Vaccines Market Challenges
  • Table 117. Hepatitis B Vaccines Market Restraints
  • Table 118. Research Programs/Design for This Report
  • Table 119. Key Data Information from Secondary Sources
  • Table 120. Key Data Information from Primary Sources
  • Table 121. Authors List of This Report

List of Figures

  • Figure 1. Product Picture of Hepatitis B Vaccines
  • Figure 2. Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
  • Figure 3. Global Hepatitis B Vaccines Market Share by Type: 2023
  • Figure 4. Global Hepatitis B Vaccines Market Share by Type: 2030
  • Figure 5. Yeast Derived Product Picture
  • Figure 6. CHO Derived Product Picture
  • Figure 7. Global Hepatitis B Vaccines Market Value by Application (2024-2030) & (US$ Million)
  • Figure 8. Global Hepatitis B Vaccines Market Share by Application: 2023
  • Figure 9. Global Hepatitis B Vaccines Market Share by Application: 2030
  • Figure 10. Children
  • Figure 11. Adult
  • Figure 12. Global Hepatitis B Vaccines Revenue, (US$ Million), 2019 VS 2024 VS 2030
  • Figure 13. Global Hepatitis B Vaccines Market Size (2019-2030) & (US$ Million)
  • Figure 14. Global Hepatitis B Vaccines Sales (2019-2030) & (M Doses)
  • Figure 15. Global Hepatitis B Vaccines Average Price (USD/Doses) & (2019-2030)
  • Figure 16. Hepatitis B Vaccines Report Years Considered
  • Figure 17. Hepatitis B Vaccines Sales Share by Manufacturers in 2023
  • Figure 18. Global Hepatitis B Vaccines Revenue Share by Manufacturers in 2023
  • Figure 19. Global 5 Largest Hepatitis B Vaccines Players: Market Share by Revenue in Hepatitis B Vaccines in 2023
  • Figure 20. Global 9 Largest Hepatitis B Vaccines Players: Market Share by Revenue in Hepatitis B Vaccines in 2023
  • Figure 21. Global Hepatitis B Vaccines Market Size by Region (US$ Million): 2019-2030
  • Figure 22. North America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
  • Figure 23. North America Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
  • Figure 24. U.S. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 25. Canada Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 26. Mexico Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 27. Europe Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
  • Figure 28. Europe Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
  • Figure 29. Germany Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 30. France Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 31. U.K. Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 32. Italy Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 33. Benelux Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 34. Asia Pacific Hepatitis B Vaccines Sales Market Share by Region (2019-2030)
  • Figure 35. Asia Pacific Hepatitis B Vaccines Revenue Market Share by Region (2019-2030)
  • Figure 36. China Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 37. Japan Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 38. South Korea Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 39. India Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 40. Southeast Asia Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 41. South America Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
  • Figure 42. Brazil Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 43. Middle East and Africa Hepatitis B Vaccines Sales Market Share by Country (2019-2030)
  • Figure 44. Middle East and Africa Hepatitis B Vaccines Revenue Market Share by Country (2019-2030)
  • Figure 45. Middle East Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 46. Africa Hepatitis B Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
  • Figure 47. Global Sales Market Share of Hepatitis B Vaccines by Type (2019-2030)
  • Figure 48. Global Revenue Market Share of Hepatitis B Vaccines by Type (2019-2030)
  • Figure 49. Global Hepatitis B Vaccines Price (USD/Doses) by Type (2019-2030)
  • Figure 50. Global Sales Market Share of Hepatitis B Vaccines by Application (2019-2030)
  • Figure 51. Global Revenue Market Share of Hepatitis B Vaccines by Application (2019-2030)
  • Figure 52. Global Hepatitis B Vaccines Price (USD/Doses) by Application (2019-2030)
  • Figure 53. Hepatitis B Vaccines Value Chain
  • Figure 54. Hepatitis B Vaccines Production Process (Yeast Derived)
  • Figure 55. Channels of Distribution
  • Figure 56. Bottom-up and Top-down Approaches for This Report
  • Figure 57. Data Triangulation
  • Figure 58. Key Executives Interviewed
目次

The global Hepatitis B Vaccines market was valued at US$ 1269 million in 2023 and is anticipated to reach US$ 1985 million by 2030, witnessing a CAGR of 6.45% during the forecast period 2024-2030.

North American market for Hepatitis B Vaccines is estimated to increase from $ 568 million in 2023 to reach $ 964 million by 2030, at a CAGR of 7.48% during the forecast period of 2024 through 2030.

Asia-Pacific market for Hepatitis B Vaccines is estimated to increase from $ 397.5 million in 2023 to reach $ 554.68 million by 2030, at a CAGR of 4.92% during the forecast period of 2024 through 2030.

The major global manufacturers of Hepatitis B Vaccines include GSK, NCPC, Merck, Bio Kangtai, Dynavax, AIM Vaccine, KM Biologics, LG Life Sciences, Serum Institute, etc. In 2023, the world's top five vendors accounted for approximately 79.66% of the revenue.

This report aims to provide a comprehensive presentation of the global market for Hepatitis B Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hepatitis B Vaccines.

The Hepatitis B Vaccines market size, estimations, and forecasts are provided in terms of sales volume (M Doses) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hepatitis B Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Hepatitis B Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • GSK
  • NCPC
  • Merck
  • Bio Kangtai
  • Dynavax
  • AIM Vaccine
  • KM Biologics
  • LG Life Sciences
  • Serum Institute

Segment by Type

  • Yeast Derived
  • CHO Derived

Segment by Application

  • Children
  • Adult

Consumption by Region

  • North America
  • U.S.
  • Canada
  • Mexico
  • Asia-Pacific
  • China
  • Japan
  • South Korea
  • India
  • Southeast Asia
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Benelux
  • Rest of Europe
  • South America
  • Brazil
  • Other
  • Middle East & Africa
  • Middle East
  • Africa

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Detailed analysis of Hepatitis B Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Sales, revenue of Hepatitis B Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 9: The main points and conclusions of the report.

Table of Contents

1 Hepatitis B Vaccines Market Overview

  • 1.1 Product Definition
  • 1.2 Hepatitis B Vaccines by Type
    • 1.2.1 Global Hepatitis B Vaccines Market Value Comparison by Type (2024-2030)
    • 1.2.2 Yeast Derived
    • 1.2.3 CHO Derived
  • 1.3 Hepatitis B Vaccines by Application
    • 1.3.1 Global Hepatitis B Vaccines Market Value by Application (2024-2030)
    • 1.3.2 Children
    • 1.3.3 Adult
  • 1.4 Global Hepatitis B Vaccines Market Size Estimates and Forecasts
    • 1.4.1 Global Hepatitis B Vaccines Revenue 2019-2030
    • 1.4.2 Global Hepatitis B Vaccines Sales 2019-2030
    • 1.4.3 Global Hepatitis B Vaccines Market Average Price (2019-2030)
  • 1.5 Assumptions and Limitations

2 Hepatitis B Vaccines Market Competition by Manufacturers

  • 2.1 Global Hepatitis B Vaccines Sales Market Share by Manufacturers (2019-2024)
  • 2.2 Global Hepatitis B Vaccines Revenue Market Share by Manufacturers (2019-2024)
  • 2.3 Global Hepatitis B Vaccines Average Price by Manufacturers (2019-2024)
  • 2.4 Global Key Players of Hepatitis B Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
  • 2.5 Global Key Manufacturers of Hepatitis B Vaccines, Manufacturing Sites & Headquarters
  • 2.6 Global Key Manufacturers of Hepatitis B Vaccines, Product Type & Application
  • 2.7 Global Key Manufacturers of Hepatitis B Vaccines, Date of Enter into This Industry
  • 2.8 Global Hepatitis B Vaccines Market Competitive Situation and Trends
    • 2.8.1 Global Hepatitis B Vaccines Market Concentration Rate
    • 2.8.2 The Global 5 and 9 Largest Hepatitis B Vaccines Players Market Share by Revenue
    • 2.8.3 Global Hepatitis B Vaccines Market by Company Type (Tier 1, Tier 2, and Tier 3)
  • 2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Hepatitis B Vaccines Market Scenario by Region

  • 3.1 Global Hepatitis B Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
  • 3.2 Global Hepatitis B Vaccines Sales by Region: 2019-2030
    • 3.2.1 Global Hepatitis B Vaccines Sales by Region: 2019-2024
    • 3.2.2 Global Hepatitis B Vaccines Sales by Region: 2025-2030
  • 3.3 Global Hepatitis B Vaccines Revenue by Region: 2019-2030
    • 3.3.1 Global Hepatitis B Vaccines Revenue by Region: 2019-2024
    • 3.3.2 Global Hepatitis B Vaccines Revenue by Region: 2025-2030
  • 3.4 North America Hepatitis B Vaccines Market Facts & Figures by Country
    • 3.4.1 North America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
    • 3.4.2 North America Hepatitis B Vaccines Sales by Country (2019-2030)
    • 3.4.3 North America Hepatitis B Vaccines Revenue by Country (2019-2030)
    • 3.4.4 U.S.
    • 3.4.5 Canada
    • 3.4.6 Mexico
  • 3.5 Europe Hepatitis B Vaccines Market Facts & Figures by Country
    • 3.5.1 Europe Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
    • 3.5.2 Europe Hepatitis B Vaccines Sales by Country (2019-2030)
    • 3.5.3 Europe Hepatitis B Vaccines Revenue by Country (2019-2030)
    • 3.5.4 Germany
    • 3.5.5 France
    • 3.5.6 U.K.
    • 3.5.7 Italy
    • 3.5.8 Benelux
  • 3.6 Asia Pacific Hepatitis B Vaccines Market Facts & Figures by Region
    • 3.6.1 Asia Pacific Hepatitis B Vaccines Market Size by Region: 2019 VS 2023 VS 2030
    • 3.6.2 Asia Pacific Hepatitis B Vaccines Sales by Region (2019-2030)
    • 3.6.3 Asia Pacific Hepatitis B Vaccines Revenue by Region (2019-2030)
    • 3.6.4 China
    • 3.6.5 Japan
    • 3.6.6 South Korea
    • 3.6.7 India
    • 3.6.8 Southeast Asia
  • 3.7 South America Hepatitis B Vaccines Market Facts & Figures by Country
    • 3.7.1 South America Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
    • 3.7.2 South America Hepatitis B Vaccines Sales by Country (2019-2030)
    • 3.7.3 South America Hepatitis B Vaccines Revenue by Country
    • 3.7.4 Brazil
  • 3.8 Middle East and Africa Hepatitis B Vaccines Market Facts & Figures by Country
    • 3.8.1 Middle East and Africa Hepatitis B Vaccines Market Size by Country: 2019 VS 2023 VS 2030
    • 3.8.2 Middle East and Africa Hepatitis B Vaccines Sales by Country (2019-2030)
    • 3.8.3 Middle East and Africa Hepatitis B Vaccines Revenue by Country
    • 3.8.4 Middle East
    • 3.8.5 Africa

4 Segment by Type

  • 4.1 Global Hepatitis B Vaccines Sales by Type (2019-2030)
    • 4.1.1 Global Hepatitis B Vaccines Sales by Type (2019-2024)
    • 4.1.2 Global Hepatitis B Vaccines Sales by Type (2025-2030)
    • 4.1.3 Global Hepatitis B Vaccines Sales Market Share by Type (2019-2030)
  • 4.2 Global Hepatitis B Vaccines Revenue by Type (2019-2030)
    • 4.2.1 Global Hepatitis B Vaccines Revenue by Type (2019-2024)
    • 4.2.2 Global Hepatitis B Vaccines Revenue by Type (2025-2030)
    • 4.2.3 Global Hepatitis B Vaccines Revenue Market Share by Type (2019-2030)
  • 4.3 Global Hepatitis B Vaccines Price by Type (2019-2030)

5 Segment by Application

  • 5.1 Global Hepatitis B Vaccines Sales by Application (2019-2030)
    • 5.1.1 Global Hepatitis B Vaccines Sales by Application (2019-2024)
    • 5.1.2 Global Hepatitis B Vaccines Sales by Application (2025-2030)
    • 5.1.3 Global Hepatitis B Vaccines Sales Market Share by Application (2019-2030)
  • 5.2 Global Hepatitis B Vaccines Revenue by Application (2019-2030)
    • 5.2.1 Global Hepatitis B Vaccines Revenue by Application (2019-2024)
    • 5.2.2 Global Hepatitis B Vaccines Revenue by Application (2025-2030)
    • 5.2.3 Global Hepatitis B Vaccines Revenue Market Share by Application (2019-2030)
  • 5.3 Global Hepatitis B Vaccines Price by Application (2019-2030)

6 Key Companies Profiled

  • 6.1 GSK
    • 6.1.1 GSK Company Information
    • 6.1.2 GSK Description and Business Overview
    • 6.1.3 GSK Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.1.4 GSK Hepatitis B Vaccines Product Portfolio
  • 6.2 NCPC
    • 6.2.1 NCPC Company Information
    • 6.2.2 NCPC Description and Business Overview
    • 6.2.3 NCPC Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.2.4 NCPC Hepatitis B Vaccines Product Portfolio
  • 6.3 Merck
    • 6.3.1 Merck Company Information
    • 6.3.2 Merck Description and Business Overview
    • 6.3.3 Merck Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.3.4 Merck Hepatitis B Vaccines Product Portfolio
  • 6.4 Bio Kangtai
    • 6.4.1 Bio Kangtai Company Information
    • 6.4.2 Bio Kangtai Description and Business Overview
    • 6.4.3 Bio Kangtai Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.4.4 Bio Kangtai Hepatitis B Vaccines Product Portfolio
  • 6.5 Dynavax
    • 6.5.1 Dynavax Company Information
    • 6.5.2 Dynavax Description and Business Overview
    • 6.5.3 Dynavax Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.5.4 Dynavax Hepatitis B Vaccines Product Portfolio
    • 6.5.5 Dynavax Recent Developments/Updates
  • 6.6 AIM Vaccine
    • 6.6.1 AIM Vaccine Company Information
    • 6.6.2 AIM Vaccine Description and Business Overview
    • 6.6.3 AIM Vaccine Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.6.4 AIM Vaccine Hepatitis B Vaccines Product Portfolio
  • 6.7 KM Biologics
    • 6.7.1 KM Biologics Company Information
    • 6.7.2 KM Biologics Description and Business Overview
    • 6.7.3 KM Biologics Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.7.4 KM Biologics Hepatitis B Vaccines Product Portfolio
  • 6.8 LG Life Sciences
    • 6.8.1 LG Life Sciences Company Information
    • 6.8.2 LG Life Sciences Description and Business Overview
    • 6.8.3 LG Life Sciences Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.8.4 LG Life Sciences Hepatitis B Vaccines Product Portfolio
    • 6.8.5 LG Life Sciences Recent Developments/Updates
  • 6.9 Serum Institute
    • 6.9.1 Serum Institute Company Information
    • 6.9.2 Serum Institute Description and Business Overview
    • 6.9.3 Serum Institute Hepatitis B Vaccines Sales, Revenue and Gross Margin (2019-2024)
    • 6.9.4 Serum Institute Hepatitis B Vaccines Product Portfolio

7 Industry Chain and Sales Channels Analysis

  • 7.1 Hepatitis B Vaccines Industry Chain Analysis
  • 7.2 Hepatitis B Vaccines Key Raw Materials
    • 7.2.1 Key Raw Materials
    • 7.2.2 Raw Materials Key Suppliers
  • 7.3 Hepatitis B Vaccines Production Mode & Process
  • 7.4 Hepatitis B Vaccines Sales and Marketing
    • 7.4.1 Hepatitis B Vaccines Sales Channels
    • 7.4.2 Hepatitis B Vaccines Distributors
  • 7.5 Hepatitis B Vaccines Customers

8 Hepatitis B Vaccines Market Dynamics

  • 8.1 Hepatitis B Vaccines Industry Trends
  • 8.2 Hepatitis B Vaccines Market Drivers
  • 8.3 Hepatitis B Vaccines Market Challenges
  • 8.4 Hepatitis B Vaccines Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

  • 10.1 Methodology/Research Approach
    • 10.1.1 Research Programs/Design
    • 10.1.2 Market Size Estimation
    • 10.1.3 Market Breakdown and Data Triangulation
  • 10.2 Data Source
    • 10.2.1 Secondary Sources
    • 10.2.2 Primary Sources
  • 10.3 Author List
  • 10.4 Disclaimer